Envoy Medical, Inc.COCHNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank40
3Y CAGR-44.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-44.5%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 6.90% |
| 2024 | -4.14% |
| 2023 | 157.35% |
| 2022 | 40.32% |
| 2021 | 352681.74% |
| 2020 | 0.00% |